Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

clear cell renal cell carcinoma; prognosis; plasma; PD-1; PD-L1; renal cell carcinoma; immune checkpoint inhibitors; immune related adverse events (irAEs); thyroid; cutaneous; biomarker; DNA methylation; epigenetics; kidney; hypoxia; tumor microenvironment; SCD-1; oleic acid; renal cancer; sunitinib; resistance; miRNA; transcriptome; pathway analysis; nivolumab; tissue slice culture; PD1; T-cells; metastatic clear cell renal cell carcinoma; first-line treatment; immunotherapy; tyrosine kinase inhibitors; combinations; single-cell RNA sequencing; immune landscape; cancer immunotherapy; intra-tumoral heterogeneity; inter-tumoral heterogeneity; inter-metastatic heterogeneity; renal cell cancer; treatment resistance; angiogenesis; adjuvant therapy; prediction model; prognostic factor; clear cell kidney cancer; radiogenomics; radiomics; machine learning; gene expression; cystic tumor; imaging; magnetic resonance; surgery; ddPCR; circulating miRNA; diagnosis; malignancy; histomorphological features; PBRM1; immunohistochemistry; architectural patterns; endothelial cells; translational; immune checkpoint inhibitor; responsiveness; molecular features; multisite tumor sampling; intratumor heterogeneity; clear-cell renal cell carcinoma; disease progression; prognostic factors; biomarkers; RNA sequencing; n/a